Impact stories: Oncology and cardiovascular biology
Showcasing our grant holders and how NC3Rs-funded research comes together to develop innovative new 3Rs tools and technologies that are pioneering better science.
Our latest three impact stories focus on oncology and cardiovascular biology, representing over £500k of investment from NC3Rs and The British Heart Foundation (BHF) to the University of Glasgow, University of Cambridge and Keele University.
Replacing mice and improving Glioblastoma outcomes
Professor Anthony Chalmers and Co-Investigator Dr Natividad Gomez-Roman have further developed a 3D human cell culture model replacing the use of mice to evaluate and screen treatments for Glioblastoma (GBM). Hear how developing this model has impacted their research and careers.
Forming clots in in vitro blood flow
Dr Alan Harper and NC3Rs-BHF PhD Student Jacob Ranjbar have developed an artificial human blood vessel to study blood clotting in vitro and replace the use of mice in thrombosis research. They have successfully disseminated the model to the thrombosis community, including for new applications within cardiovascular research.
Screening chemoprevention strategies for squamous lung cancer
Dr Frank McCaughan and student, Dr Phil Barry, miniaturised a human cell-based model of early-stage lung cancer enabling the assay to replace some drug screening experiments using mice.
We have an entirely new programme building lungs in the laboratory and this would not have happened without the confidence in in vitro human models engendered by our NC3Rs funding.
Dr Frank McCaughan